These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33586067)

  • 1. ASO Author Reflections: R Status Is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma.
    Crippa S; Giannone F; Lena MS; Falconi M
    Ann Surg Oncol; 2021 Aug; 28(8):4613-4614. PubMed ID: 33586067
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: The Challenge of Minimal Residual Disease.
    Belfiori G; Crippa S; Falconi M
    Ann Surg Oncol; 2024 Jun; 31(6):4115-4116. PubMed ID: 38472672
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: Do Distinct Patterns of Recurrence Impact the Prognosis of Patients With Resected Pancreatic Ductal Adenocarcinoma?
    Groot VP; Wolfgang CL; He J
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):806-807. PubMed ID: 30298312
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma.
    Malleo G; Maggino L; Fernàndez-Del Castillo C; Salvia R
    Ann Surg Oncol; 2020 Oct; 27(10):3913-3914. PubMed ID: 32399766
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: Chemopreventive Agents After Pancreatic Resection for Ductal Adenocarcinoma.
    Tamburrino D; Guarneri G; Capurso G; Falconi M
    Ann Surg Oncol; 2021 Apr; 28(4):2323-2324. PubMed ID: 32929602
    [No Abstract]   [Full Text] [Related]  

  • 6. R Status is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma.
    Crippa S; Giannone F; Schiavo Lena M; Belfiori G; Partelli S; Tamburrino D; Delpini R; Pagnanelli M; Pecorelli N; Balzano G; Doglioni C; Falconi M
    Ann Surg Oncol; 2021 Aug; 28(8):4602-4612. PubMed ID: 33393031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ASO Visual Abstract: Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: Proof of Concept for a "Biologic R2 Definition".
    Belfiori G; Crippa S; Pagnanelli M; Gasparini G; Aleotti F; Camisa PR; Partelli S; Pecorelli N; De Stefano F; Lena MS; Palumbo D; Tamburrino D; Reni M; Falconi M
    Ann Surg Oncol; 2024 Jun; 31(6):4119-4120. PubMed ID: 38528177
    [No Abstract]   [Full Text] [Related]  

  • 8. Biomarkers as predictors of recurrence following curative resection for pancreatic ductal adenocarcinoma: a review.
    Osayi SN; Bloomston M; Schmidt CM; Ellison EC; Muscarella P
    Biomed Res Int; 2014; 2014():468959. PubMed ID: 25050350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASO Author Reflections: Resection Margins in Distal Pancreatectomy for Ductal Adenocarcinoma-Does Surgery Tell the Whole Story?
    Sahakyan MA; Labori KJ; Edwin B
    Ann Surg Oncol; 2022 Jan; 29(1):376-377. PubMed ID: 34304314
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: Exploring the Oncologic Impact of Pancreatic Fistula after Distal Pancreatectomy for Ductal Adenocarcinoma.
    Leon P; Panaro F
    Ann Surg Oncol; 2021 Jun; 28(6):3184-3185. PubMed ID: 33221981
    [No Abstract]   [Full Text] [Related]  

  • 11. ASO Author Reflections: Prognostic Value of Tumor Deposits in Resected Pancreatic Ductal Adenocarcinoma.
    Hua J; Shi S
    Ann Surg Oncol; 2023 May; 30(5):3045. PubMed ID: 36695995
    [No Abstract]   [Full Text] [Related]  

  • 12. ASO Author Reflections: Prognostic Value of the Preoperative Tumor Marker Index in Resected Pancreatic Ductal Adenocarcinoma: A Retrospective Single Institutional Study.
    Miyata T; Hayashi H; Baba H
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):903-904. PubMed ID: 32840745
    [No Abstract]   [Full Text] [Related]  

  • 13. [R classification and pancreatic ductal adenocarcinoma--R 0 is R 0].
    Munding J; Uhl W; Tannapfel A
    Z Gastroenterol; 2011 Oct; 49(10):1423-7. PubMed ID: 21964897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the Value of Total Mesopancreas Excision in Pancreatic Ductal Adenocarcinoma? Current Evidence of the Literature.
    Popescu I; Dumitrascu T
    Chirurgia (Bucur); 2018; 113(3):335-343. PubMed ID: 29981664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASO Author Reflections: Margin-Positive Pancreatic Ductal Adenocarcinoma During Pancreaticoduodenectomy: Additional Resection Does Not Improve Survival.
    Zheng R; Nauheim D; Bassig J; Chadwick M; Schultz CW; Krampitz G; Lavu H; Winter JR; Yeo CJ; Berger AC
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):895-896. PubMed ID: 32813199
    [No Abstract]   [Full Text] [Related]  

  • 16. ASO Author Reflections: Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinoma of the Body and Tail.
    Kitamura K; Esaki M; Sone M; Sugawara S; Hiraoka N; Nara S; Ban D; Takamoto T; Mizui T; Shimada K
    Ann Surg Oncol; 2022 Oct; 29(11):7059-7060. PubMed ID: 35648319
    [No Abstract]   [Full Text] [Related]  

  • 17. ASO Author Reflections: Prognostic Index after Neoadjuvant Chemotherapy (PINC) in Pancreatic Ductal Adenocarcinoma as Novel Tumor Regression Grading System.
    Redegalli M; Schiavo Lena M
    Ann Surg Oncol; 2022 Jun; 29(6):3503. PubMed ID: 35187623
    [No Abstract]   [Full Text] [Related]  

  • 18. ASO Author Reflections: Positive Status of Intraoperative Peritoneal Lavage Cytology in Patients with Pancreatic Ductal Adenocarcinoma: Are They Candidates for Radical Resection?
    Kawakatsu S; Shimizu Y; Matsuo K; Hosoda W
    Ann Surg Oncol; 2022 Sep; 29(9):5984-5985. PubMed ID: 35441307
    [No Abstract]   [Full Text] [Related]  

  • 19. ASO Author Reflections: Lymphadenectomy in Distal Pancreatectomy for Ductal Adenocarcinoma: How to Do Better?
    Wang W; Shen B
    Ann Surg Oncol; 2022 Mar; 29(3):1540-1541. PubMed ID: 34586523
    [No Abstract]   [Full Text] [Related]  

  • 20. ASO Author Reflections: Pancreatic Invasion is a Crucial Independent Prognostic Factor in Duodenal Carcinoma.
    Nitta N; Ohgi K; Sugiura T; Okamura Y; Ito T; Yamamoto Y; Ashida R; Sasaki K; Uesaka K
    Ann Surg Oncol; 2020 Oct; 27(11):4561. PubMed ID: 32462525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.